Functional Characterization of BbroAFP Reveals Its Pleiotropic Antifungal Activity in

Arda Örçen, Yunus Doğan, Amjad Tulimat, Beyza Goncu, Batu Erman, Günseli Bayram Akçapınar

Abstract read

In one paragraph

Article in Journal of fungi (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Arda ÖrçenDepartment of Medical Biotechnology, Graduate School of Health Sciences, Acıbadem Mehmet Ali Aydınlar University, Istanbul 34752, Türkiye.ORCID 0000-0002-1522-7051

Yunus DoğanNanomik Biyoteknoloji A.Ş., Istanbul 34400, Türkiye.ORCID 0000-0002-9587-8400

Amjad TulimatNanomik Biyoteknoloji A.Ş., Istanbul 34400, Türkiye.ORCID 0009-0006-2179-0357

Beyza GoncuDepartment of Medical Services and Techniques, Bezmialem Vakif University, Istanbul 34093, Türkiye.ORCID 0000-0001-6026-8218

Batu ErmanDepartment of Molecular Biology and Genetics, Faculty of Engineering and Natural Sciences, Acıbadem Mehmet Ali Aydınlar University, Istanbul 34752, Türkiye.ORCID 0000-0003-2180-7607

Günseli Bayram AkçapınarDepartment of Medical Biotechnology, Graduate School of Health Sciences, Acıbadem Mehmet Ali Aydınlar University, Istanbul 34752, Türkiye.ORCID 0000-0002-6296-7415

Funding

Acıbadem University Internal FundsNanomik Biyoteknoloji A.Ş. Internal Funds

6 · The paper itself

Abstract

Fungal pathogens pose a major threat to global agriculture and human health, necessitating alternative antifungal strategies with high efficacy and low resistance potential. Antifungal proteins (AFPs) from filamentous fungi are promising candidates due to their stability, selectivity, and diverse mechanisms of action. Here, we characterize

Indexed as

antifungal proteinBeauveria brongniartiibiofungicideBotrytis cinereacysteine-rich peptidemetacaspasePichia pastoris

Identifiers

PMID42187789

DOI10.3390/jof12050305

PMCPMC13207606

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.